---
schema_version: "secwatch.filing_event.v1"
accession: "0001193805-23-000557"
form_type: "8-K"
ticker: null
cik: "0001497504"
company_name: "PLx Pharma Winddown Corp."
filed_at: "2023-04-13T23:59:59+00:00"
generated_at: "2026-06-17T02:35:49.964634+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# PLx Pharma files Chapter 11, enters stalking horse asset sale agreement with Greenwood Brands

## Summary
- Filed voluntary Chapter 11 petitions in Delaware (Case Nos. 23-10456 and 23-10457) on April 13, 2023.
- Stalking horse asset purchase agreement with PLx Acquisition Company LLC (Greenwood Brands) to sell substantially all assets.
- Sale subject to Bankruptcy Court approval, higher bids, and other conditions; equity holders likely receive no recovery.
- Common stock began trading on OTC Pink under symbol PLXP on April 13, 2023.

## SEC filing metadata
- accession: 0001193805-23-000557
- form_type: 8-K
- cik: 0001497504
- company_name: PLx Pharma Winddown Corp.
- filed_at: 2023-04-13T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 1.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1497504/000119380523000557/0001193805-23-000557-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1497504/000119380523000557/e618499_8k-plx.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193805-23-000557
- JSON: https://secwatch.observer/filing/0001193805-23-000557.json
- Plain text: https://secwatch.observer/filing/0001193805-23-000557.txt

## Key facts
- Distress & Bankruptcy
  PLx Pharma Winddown Corp. entered chapter 11 in United States Bankruptcy Court for the District of Delaware (petition 2023-04-13).
  - Proceeding: chapter 11
  - Court: United States Bankruptcy Court for the District of Delaware
  - Petition: 2023-04-13
  source text: On April 13, 2023, PLx Pharma Inc. (the “Company”) and its wholly-owned subsidiary, PLx Opco Inc. (together with the Company, the “Debtors”), filed voluntary petitions (Case Nos. 23-10456 and 23-10457) (the “Chapter 11 Cases”) for relief under Chapter 11 of title 11 of the United States Bankruptcy Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1497504/000119380523000557/0001193805-23-000557-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.